Germany’s CureVac plans global late-stage COVID-19 vaccine trial in fourth quarter

By: |
Updated: Sep 30, 2020 12:25 PM

The company's U.S.-listed shares rose 10% to $49.66 in extended trading.CureVac has dosed the first patient with its experimental COVID-19 vaccine in the trial taking place in Peru and Panama and expects data on older adults in the fourth quarter.

Germany, CureVac, COVID-19 vaccine, Novavax Inc, AstraZeneca, German government, covid 19 pandemic, latest news on covid 19 vaccineThe vaccine developer plans to start the global trial after data from the ongoing studies.CureVac is among the many in the race to develop a vaccine for COVID-19. (Photo source: Reuters)

Germany’s CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.

The company’s U.S.-listed shares rose 10% to $49.66 in extended trading. CureVac has dosed the first patient with its experimental COVID-19 vaccine in the trial taking place in Peru and Panama and expects data on older adults in the fourth quarter.

The vaccine developer plans to start the global trial after data from the ongoing studies.CureVac is among the many in the race to develop a vaccine for COVID-19, with rivals including Novavax Inc and AstraZeneca already conducting late-stage trials of their potential vaccines.

CureVac bagged nearly $300 million in funding from the German government earlier this month to speed up work on its prototype COVID-19 vaccine and build capacity to produce it at scale.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 unlock: Delhi govt allows maximum 200 persons at marriage gatherings in closed spaces
2Covid-19: 413 more test positive in Uttarakhand
3Impossible to wipe off COVID spread through lockdown, treat mask as vaccine: Satyendar Jain